×
About 628 results

ALLMedicine™ Pediatric Atopic Dermatitis Center

Research & Reviews  167 results

Biologics for pediatric atopic dermatitis: A protocol of a systematic review and meta-a...
https://doi.org/10.1371/journal.pone.0271712
PloS One; Cao R, Lu J et. al.

Feb 4th, 2023 - Atopic dermatitis is a chronic pruritic inflammatory skin disease commonly occurring in children. The objective of this study is to evaluate the treatment of pediatric atopic dermatitis with biologics, as they have displayed immense promising resu...

Shedding light on key pharmacological knowledge and strategies for pediatric atopic der...
https://doi.org/10.1080/17512433.2023.2173172
Expert Review of Clinical Pharmacology; Moreno A, Renert-Yuval Y et. al.

Jan 28th, 2023 - Atopic dermatitis (AD) is an inflammatory disease affecting over 20% of the pediatric population, with 85% of cases presenting before the age of five. Recently, therapeutic options in pediatric patients have evolved rapidly, following extensive de...

Assessment of the Effect of Coconut and Sunflower Seed Oil Derived Isosorbide Diseters and Colloidial Oatmeal
https://clinicaltrials.gov/ct2/show/NCT05688735

Jan 18th, 2023 - The goal of this study is to compare coconut oil and sunflower seed oil derived isosorbide disesters and colloidal oatmeal, and observe their effect on pediatric atopic dermatitis among males and females aged 2-17.

Past, Present, and Future of Pediatric Atopic Dermatitis Management.
https://doi.org/10.12788/cutis.0653
Cutis Haft MA, Sui JY et. al.

Jan 14th, 2023 - Past, Present, and Future of Pediatric Atopic Dermatitis Management.|2023|Haft MA,Sui JY,Choi M,Eichenfield LF,|diagnosis,therapy,

Dupilumab in daily practice for the treatment of pediatric atopic dermatitis: 28-week c...
https://doi.org/10.1111/pai.13887
Pediatric Allergy and Immunology : Official Publication O... Kamphuis E, Boesjes CM et. al.

Dec 25th, 2022 - Dupilumab has proven to be an effective and safe treatment for atopic dermatitis (AD) in pediatric patients in clinical trials. However, few daily practice studies are available. The aim of this study is to evaluate the effect of 28 weeks dupiluma...

see more →

Clinicaltrials.gov  20 results

Assessment of the Effect of Coconut and Sunflower Seed Oil Derived Isosorbide Diseters and Colloidial Oatmeal
https://clinicaltrials.gov/ct2/show/NCT05688735

Jan 18th, 2023 - The goal of this study is to compare coconut oil and sunflower seed oil derived isosorbide disesters and colloidal oatmeal, and observe their effect on pediatric atopic dermatitis among males and females aged 2-17.

Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis
https://clinicaltrials.gov/ct2/show/NCT01782703

Apr 6th, 2022 - Objectives: To define the cellular and molecular biomarkers of atopic dermatitis in skin biopsies and blood samples from a pre-adolescent pediatric population and correlate it with disease severity. To measure the skin barrier in atopic dermatitis...

Clinical vs. Anecdotal Evidence - Pediatric Atopic Dermatitis
https://clinicaltrials.gov/ct2/show/NCT03559075

Feb 18th, 2022 - Atopic dermatitis is the most common chronic, inflammatory dermatologic condition in young children, with a prevalence approaching 25% in some countries. Topical corticosteroids, the mainstay treatment in managing atopic dermatitis, generally func...

Health Literacy for Children With Atopic Dermatitis and Their Caregivers
https://clinicaltrials.gov/ct2/show/NCT01138761

Oct 28th, 2021 - The purpose of this study is to determine the effectiveness of additional nursing instruction for the caregivers of newly diagnosed pediatric atopic dermatitis patients at the University of Missouri Dermatology clinic. Caregivers of children with ...

The Role of Bathing Additives in the Treatment of Pediatric Atopic Dermatitis
https://clinicaltrials.gov/ct2/show/NCT03775590

May 12th, 2021 - To perform a randomized controlled study to evaluate the efficacy of adding dilute acetic acid to the bath twice weekly on the Eczema Area and Severity Index (EASI) score as compared to adding dilute bleach to the bath including a control arm in w...

see more →

News  64 results

Dupilumab is clinically effective and safe for treating pediatric atopic dermatitis in daily practice
https://www.mdedge.com/dermatology/article/260251/atopic-dermatitis/dupilumab-clinically-effective-and-safe-treating

Dec 19th, 2022 - Key clinical point: Dupilumab decreases disease severity, disease-associated symptoms, and severity-associated serum biomarker levels in pediatric patients with atopic dermatitis (AD) in daily practice. Major finding: At week 28, 49.

Proactive TCS fails to reduce relapse rate in moderate-to-severe atopic dermatitis
https://www.mdedge.com/dermatology/article/259577/atopic-dermatitis/proactive-tcs-fails-reduce-relapse-rate-moderate-severe

Nov 18th, 2022 - Key clinical point: Although proactive (PA) topical corticosteroid (TCS) therapy did not show lower relapse rates in pediatric patients with moderate-to-severe atopic dermatitis (AD) in remission, it was more effective against itch and as safe as.

Past, Present, and Future of Pediatric Atopic Dermatitis Management
https://www.mdedge.com/dermatology/article/259214/atopic-dermatitis/past-present-and-future-pediatric-atopic-dermatitis
Michael Amin Haft, MD, Jennifer Yuan Sui, BA et. al.

Nov 4th, 2022 - Atopic dermatitis (AD), or eczema, is a common inflammatory skin disease notorious for its chronic, relapsing, and often frustrating disease course. Although as many as 25% of children in the United States are affected by this condition and its im.

Pediatric atopic dermatitis and neuropsychiatric disorders: What is the link?
https://www.mdedge.com/dermatology/article/258037/atopic-dermatitis/pediatric-atopic-dermatitis-and-neuropsychiatric

Sep 19th, 2022 - Key clinical point: Atopic dermatitis (AD) did not increase the incidence risk for most neuropsychiatric disorders in a pediatric cohort. Major finding: The risks for attention deficit hyperactivity disorder (hazard ratio [HR] 1.

Pediatric atopic dermatitis: Food allergy common but AD rarely triggered by food
https://www.mdedge.com/dermatology/article/256551/atopic-dermatitis/pediatric-atopic-dermatitis-food-allergy-common-ad

Jul 27th, 2022 - Key clinical point: Although food allergy (FA) is common among pediatric patients with atopic dermatitis (AD), immunoglobulin E (IgE) mediates the majority of instances and very few patients report food-triggered AD (FTAD), cautioning against unne.

see more →